logo

For the Inventor, By the Inventor

Surrey, United Kingdom

Patricia McLean

This inventor holds 3 USPTO granted patents. Top assignees: Rodaris Pharmaceuticals Limited, Sylus Pharmaceuticals Ltd.. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patricia McLean. Retrieved from https://idiyas.com/inventor/patricia-mclean

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal2 out of 6 
 
Rodaris Pharmaceuticals Limited
 patents
silverMedal1 out of 1 
 
Sylus Pharmaceuticals Ltd.
 patent

Years Active: 2002-2005

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6900182 - Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury (2005-05-31),
2. 6716592 - Materials and methods relating to the diagnosis and treatment of diabetes and obesity (2004-04-06),
3. 6495330 - Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes (2002-12-17),

Title: Patricia McLean: Innovator in Medical Treatments

Introduction

Patricia McLean is an accomplished inventor based in Surrey, Great Britain. She has made significant contributions to the field of medical treatments, holding three patents that reflect her dedication to innovation and improvement in healthcare.

Latest Patents

Her latest patents showcase groundbreaking advancements in the treatment of ischaemia-reperfusion injury. One notable patent involves compositions comprising inositolphosphoglycans (IPGs) and ribose, aimed at enhancing energy generation in cells through mitochondrial oxidative restoration. This innovative treatment not only addresses ischaemic-reperfusion injury but also offers potential applications in preserving organs for transplantation. Another key patent highlights diagnostic methods for diabetes and obesity, utilizing the levels or ratios of P- and A-type inositolphosphoglycans (IPGs) in patient samples.

Career Highlights

Patricia has worked with esteemed companies, including Rodaris Pharmaceuticals Limited and Sylus Pharmaceuticals Ltd. Her experience in these organizations has further honed her expertise in developing effective medical solutions. Her patents illustrate her relentless pursuit of advancements in healthcare, demonstrating her commitment to improving patient outcomes.

Collaborations

Throughout her career, Patricia has collaborated with notable professionals in her field, including Thomas William Rademacher and Leslie Greenbaum. These collaborations have allowed her to integrate diverse insights and expertise, ultimately enriching her contributions to innovation in medical treatments.

Conclusion

Patricia McLean stands out as a visionary inventor whose work continues to have a profound impact on medicine. Through her innovative patents and collaborations, she exemplifies the spirit of creativity and dedication required to drive significant advancements in healthcare. Her ongoing passion for research and development promises to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…